系统评价和荟萃分析：药物治疗广泛性发育障碍儿童注意缺陷/多动障碍症状的效果。
Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.
机构信息
Yale School of Medicine Child Study Center, 230 South Frontage Road, New Haven, CT, 06519, USA,
出版信息
J Autism Dev Disord. 2013 Oct;43(10):2435-41. doi: 10.1007/s10803-013-1793-z.
Abstract
Many children with pervasive developmental disorders (PDD) exhibit behaviors and symptoms of attention-deficit/hyperactivity disorder (ADHD). We sought to determine the relative efficacy of medications for treating ADHD symptoms in children with PDD by identifying all double-blind, randomized, placebo-controlled trials examining the efficacy of medications for treating ADHD symptoms in children with PDD. We located seven trials involving 225 children. A random effects meta-analysis of four methylphenidate trials showed methylphenidate to be effective for treating ADHD symptoms in children with PDD (ES = .67). Several adverse events were greater for children were taking methylphenidate compared to placebo. An individual trial of clonidine and two trials of atomoxetine suggest these agents may also be effective in treating ADHD symptoms in children with PDD.
摘要
许多患有广泛性发育障碍（PDD）的儿童表现出注意力缺陷/多动障碍（ADHD）的行为和症状。我们试图通过确定所有双盲、随机、安慰剂对照试验，来确定治疗 PDD 儿童 ADHD 症状的药物的相对疗效，这些试验检查了治疗 PDD 儿童 ADHD 症状的药物的疗效。我们找到了涉及 225 名儿童的七项试验。对四项哌醋甲酯试验的随机效应荟萃分析表明，哌醋甲酯对治疗 PDD 儿童的 ADHD 症状有效（ES=0.67）。与服用安慰剂的儿童相比，服用哌醋甲酯的儿童出现了几种不良事件。一项可乐定的单独试验和两项托莫西汀的试验表明，这些药物也可能对治疗 PDD 儿童的 ADHD 症状有效。
相似文献
1
Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.系统评价和荟萃分析：药物治疗广泛性发育障碍儿童注意缺陷/多动障碍症状的效果。
J Autism Dev Disord. 2013 Oct;43(10):2435-41. doi: 10.1007/s10803-013-1793-z.
2
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍（ADHD）的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
3
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
4
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
5
Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍（ADHD）的药物治疗。
Cochrane Database Syst Rev. 2011 Apr 13(4):CD007990. doi: 10.1002/14651858.CD007990.pub2.
6
Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.儿童和青少年注意力缺陷多动障碍治疗的系统证据综合分析：赖氨酸安非他明与哌甲酯及托莫西汀的间接治疗比较
Curr Med Res Opin. 2014 Aug;30(8):1673-85. doi: 10.1185/03007995.2014.904772. Epub 2014 Apr 15.
7
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.多不饱和脂肪酸（PUFA）治疗儿童和青少年注意缺陷多动障碍（ADHD）。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
8
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
9
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍（ADHD）儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
10
A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.一项关于哌甲酯、右旋苯丙胺和托莫西汀治疗儿童及青少年注意力缺陷多动障碍的有效性及成本效益的系统评价和经济学模型。
Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. doi: 10.3310/hta10230.
引用本文的文献
1
Autism spectrum traits in adults with attention-deficit/hyperactivity disorder (ADHD): a hidden multifaceted phenotype marked by affective comorbidity, emotional dysregulation, and chronobiological disturbances.患有注意力缺陷多动障碍（ADHD）的成年人的自闭症谱系特征：一种以情感共病、情绪调节障碍和生物钟紊乱为特征的隐藏的多方面表型。
Eur Arch Psychiatry Clin Neurosci. 2025 Sep 17. doi: 10.1007/s00406-025-02114-9.
2
Available Treatments for Autism Spectrum Disorder: From Old Strategies to New Options.自闭症谱系障碍的现有治疗方法：从旧策略到新选择。
Pharmaceuticals (Basel). 2025 Feb 25;18(3):324. doi: 10.3390/ph18030324.
3
The SASOP/PsychMg child and adolescent attention-deficit/hyperactivity disorder guidelines.SASOP/PsychMg儿童及青少年注意力缺陷/多动障碍指南
S Afr J Psychiatr. 2025 Feb 25;31:2357. doi: 10.4102/sajpsychiatry.v31i0.2357. eCollection 2025.
4
Observing the behavioural effects of methylphenidate in children and adolescents with ASD-ADHD dual diagnosis: A mini review.观察哌甲酯对患有自闭症谱系障碍-注意力缺陷多动障碍双重诊断的儿童和青少年的行为影响：一项小型综述。
Front Child Adolesc Psychiatry. 2023 Mar 17;2:1052115. doi: 10.3389/frcha.2023.1052115. eCollection 2023.
5
Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms.自闭症的药物治疗：关于常见共病精神症状指南的建议
BMC Med. 2025 Jan 7;23(1):11. doi: 10.1186/s12916-024-03814-0.
6
Response inhibition as a critical executive function in differentiating attention-deficit/hyperactivity disorder from autism spectrum disorder: a comprehensive attention test study.反应抑制作为区分注意力缺陷/多动障碍与自闭症谱系障碍的关键执行功能：一项综合注意力测试研究
Front Psychiatry. 2024 Nov 5;15:1426376. doi: 10.3389/fpsyt.2024.1426376. eCollection 2024.
7
Stimulant medication and symptom interrelations in children, adolescents and adults with attention-deficit/hyperactivity disorder.患有注意力缺陷/多动障碍的儿童、青少年及成人中兴奋剂药物与症状的相互关系。
Eur Child Adolesc Psychiatry. 2024 Nov 11. doi: 10.1007/s00787-024-02610-8.
8
Discordance Between Psychiatric Diagnoses and Medication Use in Children and Adults With Autism Presenting in Crisis.自闭症儿童和成人在危机状态下精神科诊断与用药情况的不一致
Focus (Am Psychiatr Publ). 2024 Apr;22(2):150-161. doi: 10.1176/appi.focus.20230027. Epub 2024 Apr 10.
9
Long-term medication for ADHD (LMA) trial: 2-year prospective observational study in children and adolescents. Core symptoms, daily functioning, and comorbidity outcomes.ADHD 长期药物治疗（LMA）试验：儿童和青少年 2 年前瞻性观察研究。核心症状、日常功能和合并症结局。
Eur Arch Psychiatry Clin Neurosci. 2024 Jun;274(4):879-890. doi: 10.1007/s00406-023-01744-1. Epub 2024 Jan 27.
10
Association of Psychopharmacological Medication Preference with Autistic Traits and Emotion Regulation in ADHD.注意力缺陷多动障碍中精神药理药物偏好与自闭症特质及情绪调节的关联
Psychopharmacol Bull. 2023 Dec 4;53(4):23-38.
本文引用的文献
1
Are autism spectrum disorder and attention-deficit/hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample.自闭症谱系障碍和注意缺陷多动障碍是否是一种广泛存在的障碍的不同表现形式？来自临床和基于人群样本的认知和症状证据。
J Am Acad Child Adolesc Psychiatry. 2012 Nov;51(11):1160-1172.e3. doi: 10.1016/j.jaac.2012.08.024. Epub 2012 Sep 30.
2
A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.一项随机双盲研究比较托莫西汀与安慰剂治疗自闭症谱系障碍儿童注意缺陷/多动障碍症状的疗效。
J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):733-41. doi: 10.1016/j.jaac.2012.04.011. Epub 2012 May 25.
3
A systematic review of medical treatments for children with autism spectrum disorders.自闭症谱系障碍儿童的医学治疗方法的系统评价。
Pediatrics. 2011 May;127(5):e1312-21. doi: 10.1542/peds.2011-0427. Epub 2011 Apr 4.
4
Examining autistic traits in children with ADHD: does the autism spectrum extend to ADHD?探讨 ADHD 儿童的自闭症特征：自闭症谱系是否延伸至 ADHD？
J Autism Dev Disord. 2011 Sep;41(9):1178-91. doi: 10.1007/s10803-010-1135-3.
5
Autism and ADHD: how far have we come in the comorbidity debate?自闭症与注意力缺陷多动障碍：共病争论进展到哪一步了？
Neurosci Biobehav Rev. 2011 Apr;35(5):1081-8. doi: 10.1016/j.neubiorev.2010.11.002. Epub 2010 Nov 18.
6
Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders.注意缺陷多动障碍症状在自闭症谱系障碍儿童中会对认知和行为产生影响。
Autism Res. 2009 Dec;2(6):322-33. doi: 10.1002/aur.103.
7
Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.2007-2008 年全国自闭症谱系障碍儿童注册研究中的精神药物使用情况。
J Autism Dev Disord. 2010 Mar;40(3):342-51. doi: 10.1007/s10803-009-0878-1.
8
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.采用荟萃分析比较儿童和青少年多动症治疗药物的疗效。
Eur Child Adolesc Psychiatry. 2010 Apr;19(4):353-64. doi: 10.1007/s00787-009-0054-3. Epub 2009 Sep 10.
9
Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders.哌甲酯用于治疗发育障碍学龄前儿童注意力缺陷/多动障碍症状的随机、安慰剂对照、交叉研究。
J Child Adolesc Psychopharmacol. 2009 Aug;19(4):329-39. doi: 10.1089/cap.2008.0137.
10
Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: symptom or syndrome?自闭症谱系障碍儿童及青少年中的注意力缺陷/多动障碍：症状还是综合征？
J Atten Disord. 2009 Sep;13(2):117-26. doi: 10.1177/1087054708326261. Epub 2009 Apr 20.
Zotero 插件